人类免疫缺陷病毒母婴传播预防

doi:10.7504/fk2016050106

摘要/Abstract

摘要：

由于人类免疫缺陷病毒（HIV）感染人群的年轻化和治疗后生存质量的提高，有生育要求的HIV感染女性越来越多。目前我国母婴传播阻断成功率与国外发达国家还存在差距。现有的研究证实，越早确诊HIV感染、越早行抗病毒治疗，对于感染个体和预防垂直传播都有着积极的作用。除此之外，还需要根据妊娠期监测的结果，采用对应的分娩方式并配合新生儿用药预防的综合策略，以此达到最佳的阻断效果。

关键词: 人类免疫缺陷病毒, 母婴传播, 预防

Abstract:

Abstract: With the enlargement of HIV epidemic and the progress of antiretroviral therapy，more and more young people get infected and the quality of life become better and better with the antiretroviral treatment.Many of the infected women wish to get pregnancy，and thus clinical staff needs to learn how to help them to get a healthy baby.Factually，there is a gap between advanced countries and China in the rate of successful MTCT prevention.There is no doubt that diagnosing HIV and initiating antiretroviral therapy earlier will do good to the outcome of pregnancy.Additionally，appropriate mode of delivery and regimen of neonatal prophylaxis should be determined according to the results of antenatal monitoring.

Key words: HIV, mother to child transmission, prevention

中图分类号:

R14.2

孙建军，卢洪洲. 人类免疫缺陷病毒母婴传播预防[J]. 中国实用妇科与产科杂志, DOI: 10.7504/fk2016050106.

SUN Jian-jun，LU Hong-zhou.. Prevention of HIV transmission from mother to child.[J]. Acta Metallurgica Sinica, DOI: 10.7504/fk2016050106.

参考文献

[1]     Li Y，Han Y，Xie J，et al.CRF01_AE subtype is associated with X4 tropism and fast HIV progression in Chinese patients infected through sexual transmission[J].AIDS,2014,28(4):521-530.

[2]     WHO.Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants.Available at http://www.who.int/hiv/pub/mtct/antiretroviral2010/en/ Accessed (2016.2.29).

[3]     中华医学会感染病学分会艾滋病学组.艾滋病诊疗指南第三版（2015版）[J].中华临床感染病杂志,2015,8(5):385-401.

[4]     Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission.Recommendations for use of antiretroviral drugs in pregnant HIV-1infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States.Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf.Accessed (2016.2.29).

[5]     Nesheim S，Taylor A，Lampe MA，et al.A framework for elimination of perinatal transmission of HIV in the United States[J].Pediatrics,2012,130(4):738-744.

[6]     乔亚萍，王爱玲，王临虹，等.艾滋病高发地区预防HIV母婴传播项目实施效果分析[J].中国艾滋病性病,2014,20(5):343-345.

[7]     周曾全，劳云飞，陈庆玲，等.HAART预防艾滋病母婴传播的可行性和有效性[J].中国艾滋病性病,2014,20(2):76-79.

[8]      Townsend CL，Byrne L，Cortina-Borja M，et al.Earlier initiation of ART and further decline in mother-to-child HIV transmission rates，2000-2011[J].AIDS,2014,28(7):1049-1057.

[9]     Forbes JC，Alimenti AM，Singer J，et al.A national review of vertical HIV transmission[J].AIDS,2012,26(6):757-763.

[10]     World Health Organization.Hormonal contraceptive methods for women at high risk of HIV and living with HIV: 2014    guidance statement.2014.Available at http://apps.who.int/iris/bitstream/ 10665/128537/1/WHO_RHR_14.24_eng.pdf?ua=1.Accessed(2016.2.29).

[11]     Brockleburst P.The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies[J].N Engl J Med,1999,340(13):977-987.

[12]     Lennox JL，Dejesus E，Lazzarin A，et al.Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre，double-blind randomised controlled trial[J].Lancet,2009,374(9692):796-806.

[13]     Livingston EG，Huo Y，Patel K，et al.Mode of Delivery and infant respiratory morbidity among infants born to HIV-1-infected women[J].Obstet Gynecol,2010,116(2，Pt 1):335-343.

[14]     Panel on Antiretroviral Guidelines for Adults and Adolescents.Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents.2014.Available at http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf.Accessed (2016.2.

            29).

[15]     Briand N，Warszawski J，Mandelbrot L，et al.Is Intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?[J].Clin Infect Dis,2013,57(6):903-914.

[16]     Cambic CR，Avram MJ，Gupta DK，et al.Effect of ritonavir-induced cytochrome P450 3A4 inhibition on plasma fentanyl concentrations during patient-controlled epidural labor analgesia: a pharmacokinetic simulation[J].Int J Obstet Anesth,2014,23(1):45-51.

[17]     Dorenbaum A，Cunningham CK，Gelber RD，et al.Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial[J].JAMA,2002,288(2):189-198.

[18]     Ferguson W，Goode M，Walsh A，et al.Evaluation of 4 Weeks? neonatal antiretroviral prophylaxis as a component of a prevention of mother-to-child transmission program in a resource-rich setting[J].Pediatr Infect Dis J,2011,30(5):408-412.

[19]     Nielsen-Saines K，Watts DH，Veloso VG，et al.Three postpartum antiretroviral regimens to prevent intrapartum HIV infection[J].N Engl J Med,2012,366(25):2368-2379.

[20]     Ford N，Mofenson L，Shubber Z，et al.Safety of efavirenz in the first trimester of pregnancy[J].AIDS,2014,28:S123-S131.

（2016-03-01收稿）